SCHEMBL1371089

SCHEMBL1371089

COc1ccc(C(C)(O)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.51
CA1 P00915 6/20 0.50
CA2 P00918 6/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50
MAPK1 P28482 1/20 0.50
RECQL P46063 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
HSD11B1 P28845 1/20 0.46
AOC3 Q16853 1/20 0.46
PLK1 P53350 1/20 0.46
KMT2A Q03164 2/20 0.45
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404526 1.00 MAPT (0.51) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL30577887 0.84 KDM4E (0.53) ALDH1A1HSD17B10
SCHEMBL7332434 0.84 KDM4E (0.53) ALDH1A1HSD17B10
SCHEMBL8591431 0.82 MAPT (0.54) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL7358417 0.82 MAPT (0.53) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL5144776 0.82 CA1 (0.52) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL4232572 0.82 CA1 (0.52) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL2795435 0.82 CYP2C9 (0.55) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL1939457 0.82 AKR1C3 (0.54) MAPTCA1CA2ALDH1A1LMNA
SCHEMBL2327512 0.82 CA1 (0.52) MAPTCA1CA2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2646805-B1 FLUORESCENCE BASED METHOD FOR DETERMINING CONCENTRATIONS OF KEY CONSTITUENT CHEMICALS OF HONEY OR FOR DETERMINING THE BOTANICAL ORIGIN OF HONEY COMVITA NEW ZEALAND LTD (NZ) 2020-02-12 EP claimed
US-8759774-B2 Method and apparatus that utilises fluorescence to determine plant or botanical origin characteristics of honey COMVITA NEW ZEALAND LIMITED (NZ) 2014-06-24 US claimed
US-20130284945-A1 METHOD AND APPARATUS THAT UTILISES FLUORESCENCE TO DETERMINE PLANT OR BOTANICAL ORIGIN CHARACTERISTICS OF HONEY COMVITA NEW ZEALAND LIMITED (NZ) 2013-10-31 US claimed
EP-2646805-A1 A METHOD AND APPARATUS THAT UTILISES FLUORESCENCE TO DETERMINE PLANT OR BOTANICAL ORIGIN CHARACTERISTICS OF HONEY Comvita New Zealand Limited (NZ) 2013-10-09 EP claimed
WO-2012074413-A1 A METHOD AND APPARATUS THAT UTILISES FLUORESCENCE TO DETERMINE PLANT OR BOTANICAL ORIGIN CHARACTERISTICS OF HONEY COMVITA NEW ZEALAND LIMITED (NZ) 2012-06-07 WO claimed
WO-2010082844-A1 PLANT MANIPULATION COMVITA NEW ZEALAND LIMITED (NZ) 2010-07-22 WO claimed
CN-117924156-A Synthesis method of aza-aryl alcohol compound and chiral alpha-hydroxycarboxylic acid 赣南师范大学 2024-04-26 CN disclosed
US-20230339854-A1 Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors UNIV EMORY (US) 2023-10-26 US disclosed
WO-2023116774-A1 COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE 赛诺哈勃药业(成都)有限公司 2023-06-29 WO disclosed
WO-2021155367-A2 NEGATIVE ALLOSTERIC MODULATION OF GLUN3-CONTAINING N-METHYL-D-ASPARTATE RECEPTORS EMORY UNIVERSITY (US) 2021-08-05 WO disclosed
CN-111328277-A Method for reshaping keratin fibers 莱雅公司 2020-06-23 CN disclosed
CN-111295180-A Method for reshaping keratin fibers 莱雅公司 2020-06-16 CN disclosed
EP-2646805-B1 FLUORESCENCE BASED METHOD FOR DETERMINING CONCENTRATIONS OF KEY CONSTITUENT CHEMICALS OF HONEY OR FOR DETERMINING THE BOTANICAL ORIGIN OF HONEY COMVITA NEW ZEALAND LTD (NZ) 2020-02-12 EP disclosed
US-6300499-B1 α1-adrenergic receptor antagonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2001-10-09 US disclosed
US-6153768-A RECEPTOR BLOCKING ANTIESTROGENS HAVING REDUCED SIDE EFFECTS C & C RESEARCH LABORATORIES (KR) 2000-11-28 US disclosed
EP-0944613-A1 NOVEL BENZOPYRAN DERIVATIVES C & C Research Laboratories (KR) 1999-09-29 EP disclosed
WO-1998025916-A1 NOVEL BENZOPYRAN DERIVATIVES C & C RESEARCH LABORATORIES (KR) 1998-06-18 WO disclosed
EP-0816316-A1 PROCESS FOR PRODUCING 1,2-ETHANEDIOL DERIVATIVES NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1998-01-07 EP disclosed
US-4601797-A Electrochemical carboxylation of p-isobutylacetophenone and other aryl ketones MONSANTO COMPANY (US) 1986-07-22 US disclosed
US-4582577-A Electrochemical carboxylation of p-isobutylacetophenone MONSANTO COMPANY (US) 1986-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339854-A1 Negative Allosteric Modulation of GluN3-Containing N-Methyl-D-Aspartate Receptors GRIN3A, GRIN3B, GRIN1 MAPT 1473/4885CA1 2902/4885CA2 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.